Abstract
The aim of present work was to develop a new, economical & simple analytical method of Teneligliptin & its validation as per International Conference on Harmonization (ICH) guideline, which is a new antidiabetic drug that is used to treat Non-Insulin Dependent Diabetis Melitus (NIDDM) patients. A sensitive and specific Ultra Violet (UV) Visible method was developed & the analysis was carried out by using Shimazdu 1800 Spectrophotometer, 0.1(N) NaOH was used as a solvent. The UV- Visible Spectrophotometric estimation was carried out at a λ max of 242 nm using 1cm thick quartz cell. Validation of the newly developed method was performed as per International Conference on Harmonization (ICH) Q2R1 guideline in the following parameters: Calibration curve, Accuracy, Precision etc. Newly developed method obeys Beer’s-Lambert’s law in the concentration range of 5 - 25 μg / ml, whereas correlation coefficient value is less than 1. The percent amount of drug estimated by this developed method was 100.91 %, which is very close to 100 %. The validation parameters like Accuracy, Precision, Linearity, Range, Limit of detection (LOD) & Limit of Quantification (LOQ) were studied for the developed method and was found to be within the limits.
 Keywords: Teneligliptin, Validation, Method, Spectroscopy etc.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
